… of preoperative bevacizumab treatment on recovery of liver function after hepatic … liver
function in patients treated with preoperative bevacizumab was comparable to that of patients …

… undergoing resection for colorectal liver metastases (CLM). This meta-analysis evaluates
the impact of bevacizumab on parenchymal damage and functional recovery in patients …

… of bevacizumab containing preoperative chemotherapy and functional recovery of the liver
… administration of bevacizumab did not affect the functional recovery of the liver, moreover, …

… bevacizumab (atezolizumab/bevacizumab) in patients with unresectable HCC and preserved
liver function … does not appear to depress liver function, its use in patient within the Child-…

… the liver and pancreas caused by treatment with bevacizumab. Methods: We investigated 30
patients with colorectal cancer who received bevacizumab-… ) and 11 patients with colorectal …

Objective: Evaluation of the efficacy and safety of atezolizumab/bevacizumab in a real-world
HCC cohort, including patients with impaired liver function and prior systemic therapy. …

… bevacizumab (Bev) on the outcome of patients undergoing resection for colorectal liver … of
sinusoidal dilation were lower in patients treated with Bev than in patients treated without Bev (…

… ) for the non-bevacizumab group and the bevacizumab group, … the bevacizumab and 2% of
the non-bevacizumab patients … to 17 patients of the bevacizumab group and to 12 patients to …

… outcome in patients with liver metastatic CRC correlates with the level of liver function test
parameters. Methods The study included 96 patients with untreated liver metastatic CRC who …

… undergoing major hepatectomy, and that it resulted in an impaired liver functional reserve
before hepatectomy 25. The association between postoperative morbidity and sinusoidal …